Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

Clinical Infectious Diseases

Volumn 34, Issue 2, 2002, Pages 135-146

  Wong Beringer, Annie ^a   Hindler, Janet ^b   Loeloff, Michael ^c   Queenan, Anne Marie ^c   Lee, Nancy ^b   Pegues, David A ^b   Quinn, John P ^d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c R W JOHNSON PHARMACEUTICAL RES I   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFAZOLIN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; PRIORITY JOURNAL; SEPTICEMIA; TREATMENT FAILURE; TREATMENT OUTCOME;

BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; ISOELECTRIC POINT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; TREATMENT OUTCOME;

EID: 0037079878     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/324742     Document Type: Article

References (29)

1. α-lactamases in laboratory and clinical resistance
2. Laboratory capacity to detect antimicrobial resistance, 1998
3. Is it important to identify extended-spectrum α-lactamase-producing isolates?
4. Properties of plasmids responsible for production of extended-spectrum α-lactamase
5. Treatment failure due to extended spectrum α-lactamase
6. Molecular characterization by PCR-restriction length polymorphism of TEM α-lactamases
7. CDC definitions for nosocomial infections, 1988
8. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum α-lactamase
9. Novel plasmid-mediated α-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
10. Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalos-porinase and a Klebsiella pneumoniae producing an extended-spectrum α-lactamase
11. Fatal infection due to extended-spectrum α-lactamase-producing Escherichia coli: Implications for antibiotic choice for spontaneous bacterial peritonitis
12. Novel α-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to α-lactam antibiotics
13. Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymixin B: Case report and review
14. Outbreak of ceftazidime resistance due to a novel extended-spectrum α-lactamase in isolates from cancer patients
15. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
16. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 α-lactamase: Parallel outbreaks due to multiple plasmid transfer
17. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and α-lactam-α-lactamase inhibitor combinations by hyperproduction of SHV-5 α-lactamase
18. Molecular epidemiology of plasmid spread among extended broad-spectrum α-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital
19. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum α-lactamases
20. Outbreak of ceftazidime resistance caused by extended-spectrum spectrum α-lactamases at a Massachusetts chronic-care facility
21. Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit
22. Nosocomial outbreak of Klebsiella infection resistant to third-generation cephalosporins
23. Detection and clinical significance of extended-spectrum α-lactamases in a tertiary-care medical center
24. Bacteremia due to extended-spectrum α-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes
25. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation
26. Outcome of cephalosporin treatment for serious infections due to apparently susceptibe organisms producing extended-spectrum α-lactamases: Implications for clinical microbiology
27. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
28. A functional classification scheme for α-lactamases and its correlation with molecular structure